Notice2025-15283
Findings of Research Misconduct
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 12, 2025
Issuing agencies
Health and Human Services Department
Abstract
A finding of research misconduct has been made against Ryan Evanoff (Respondent), former Scientific Assistant, Department of Veterinary Microbiology and Pathology, Washington State University. Respondent engaged in research misconduct under 42 CFR part 93 in research funded by the U.S. Public Health Service (PHS), specifically National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), grant R21 AI126304. An administrative action, specifically debarment for a period of three (3) years, was implemented and is detailed below.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 153 (Tuesday, August 12, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 153 (Tuesday, August 12, 2025)]
[Notices]
[Page 38785]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-15283]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: A finding of research misconduct has been made against Ryan
Evanoff (Respondent), former Scientific Assistant, Department of
Veterinary Microbiology and Pathology, Washington State University.
Respondent engaged in research misconduct under 42 CFR part 93 in
research funded by the U.S. Public Health Service (PHS), specifically
National Institute of Allergy and Infectious Diseases (NIAID), National
Institutes of Health (NIH), grant R21 AI126304. An administrative
action, specifically debarment for a period of three (3) years, was
implemented and is detailed below.
FOR FURTHER INFORMATION CONTACT: Sheila R. Garrity, JD, MPH, MBA,
Director, Office of Research Integrity, 1101 Wootton Parkway, Suite
240, Rockville, MD 20852, (240) 453-8200.
SUPPLEMENTARY INFORMATION: Notice is hereby given that the Office of
Research Integrity (ORI) and the Suspension and Debarment Official
(SDO) have taken final action in the following case:
Ryan Evanoff, Washington State University (WSU): Based on the
preponderance of the evidence from the WSU investigation and obtained
by ORI in its oversight review, ORI found that Mr. Evanoff, former
Scientific Assistant, Department of Veterinary Microbiology and
Pathology, WSU, engaged in research misconduct under 42 CFR part 93 in
research funded by PHS, specifically NIAID, NIH, grant R21 AI126304.
ORI found by a preponderance of the evidence that Respondent
intentionally and knowingly falsified and/or fabricated the following
DNA sequences reported in research records, each of which purports to
include data from a different sequencing reaction: pC-
293_pcDNAF_CZ3082_1.seq, pC-293_pcDNAR_CZ3083_2.seq, pQ-
293_pQEfPR_CZ3084_3.seq, pQ-293_pQErev_CZ3085_4.seq, pQ-
CD81_pQEfPR_CZ3086_1.seq, and pQ-CD81_pQErev_CZ3087_2.seq.
Based on the information in the administrative record, the HHS SDO
proposed debarment under 2 CFR 180.800(b)(1)--``Violation of the terms
of a public agreement or transaction so serious as to affect the
integrity of a Federal agency program, such as willful failure to
perform in accordance with the terms of one or more public agreements
or transactions;'' and 2 CFR 180.800(d)--``Any other cause that is so
serious or compelling in nature that it affects your present
responsibility'' to protect the Federal Government's interest.
HHS provided Respondent the opportunity to contest the proposed
debarment under 42 CFR part 93 by requesting a hearing before an
administrative law judge with the HHS Departmental Appeals Board or
alternatively, in lieu of requesting a hearing, to contest under 2 CFR
part 180. Respondent did not contest within the prescribed 30-day
period. Accordingly, the following administrative action has been
implemented:
<bullet> For a period of three (3) years, beginning on June 16,
2025, Respondent is debarred from participating in ``covered
transactions'' as defined in 42 CFR Sec. 180.200 and procurement
transactions covered under the Federal Acquisition Regulation (48 CFR
chapter 1).
Dated: August 8, 2025.
Sheila R. Garrity,
Director, Office of Research Integrity, Office of the Assistant
Secretary for Health.
[FR Doc. 2025-15283 Filed 8-11-25; 8:45 am]
BILLING CODE 4150-31-P
</pre></body>
</html>Indexed from Federal Register on August 12, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.